A higher abundance of the Akkermansia bacterium in the microbiome is causally linked to hypothyroidism, suggesting a potential future treatment, according to new research.
Scientists at Duke University in North Carolina are reported to be the first to decode the genetic makeup of Akkermansia, a next-generation probiotic with potential metabolic and immunological benefits.
The recent review spotlights the efficacy of Akkermansia muciniphila in reducing the risk and progression of metabolic syndrome and type 2 diabetes (T2D), suggesting its strong potential for use for targeted dietary interventions within probiotics.
A new clinical trial has concluded that Solnul, a resistant potato starch (RPS), has prebiotic effects at low dosages, stimulating increases in beneficial health-associated bacteria and reducing diarrhoea and constipation when compared to a placebo group.
Daily supplementation with the bacterium A. muciniphila prevented negative consequences of consumption of dietary emulsifiers in a recent study of mice, with researchers postulating this was due to a direct 'shifting' of microbiota composition.
Daily supplementation with 600 mg of an elderberry extract may boost diversity of the gut microbiota, with specific increases in levels of Akkermansia, says a new study from Austria and Italy.
